drugset / Trial / NCT03513770
Autonomic Control of the Circulation and VDR
Phase 0
Recruiting
18 enrolled
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedCrossoverTriple-blindBasic science
Summary
The study objective of this project is to examine the mechanisms of the venous distension reflex (VDR) in humans. We hypothesize that COX blockade with ketorolac tromethamine, an intravenous NSAID, will attenuate the muscle sympathetic nerve activity (MSNA) response to limb venous distension. To gain further insight into whether the COX byproducts directly stimulate chemically-sensitive afferents, or enable venodilation and indirectly evoke afferent stimulation, we will measure vein size using 3T MRI during venous distention with and without ketorolac infusions.
Timeline
- Start
- 2019-08-14
- Primary completion
- 2026-11-01
- Completion
- 2027-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac Tromethamine | Small molecule | 3 mg | Intravenous |
| Subject | Ketorolac Tromethamine | Small molecule | 6 mg | Intravenous |
Indications
No indication recorded.